Literature DB >> 3492537

Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages.

T Decker, M L Lohmann-Matthes, G E Gifford.   

Abstract

Different macrophage populations were investigated for their abilities to secrete tumor necrosis factor (TNF) and to lyse TNF-susceptible tumor cells. In this way we could demonstrate that TNF-secretion, although a feature of all activated macrophage populations, is no absolute requirement for the killing of the TNF-sensitive Wehi 164 target. Macrophage cytotoxicity against this cell but not against the TNF-resistant P815 mastocytoma, was completely inhibitable by a specific anti-TNF serum also in the absence of measurable secreted TNF. Moreover the TNF-dependent lysis of tumor cells could also be performed by activated macrophages that had been fixed with paraformaldehyde before the addition of the target cells. In the indirect radioimmunoassay, TNF could be demonstrated on the surface of fixed effector cells. Our results must be interpreted in terms of membrane-associated TNF as the lytic principle for TNF-susceptible tumor cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492537

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  87 in total

1.  Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins.

Authors:  J T Safrit; B Bonavida
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 2.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

3.  Modulation of endogenous hormone action by recombinant human tumor necrosis factor.

Authors:  R S Warren; D B Donner; H F Starnes; M F Brennan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 4.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

5.  High-Intensity Exercise Prevents Disturbances in Lung Inflammatory Cytokines and Antioxidant Defenses Induced by Lipopolysaccharide.

Authors:  Gisele Henrique Cardoso; Débora Melissa Petry; Jéssica Jorge Probst; Luiz Felipe de Souza; Gabriella Ganguilhet; Franciane Bobinski; Adair R S Santos; Daniel Fernandes Martins; Kelly Cattelan Bonorino; Alcir Luiz Dafre; Deborah de C Hizume Kunzler
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

6.  Monocytes are required to prime peripheral blood T cells to undergo apoptosis.

Authors:  M X Wu; J F Daley; R A Rasmussen; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products.

Authors:  C D Kelly; C M Russo; B Y Rubin; H W Murray
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

8.  Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

Authors:  M Lewis; L A Tartaglia; A Lee; G L Bennett; G C Rice; G H Wong; E Y Chen; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

9.  Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells.

Authors:  Chinh N Tran; Steven K Lundy; Peter T White; Judith L Endres; Christopher D Motyl; Raj Gupta; Cailin M Wilke; Eric A Shelden; Kevin C Chung; Andrew G Urquhart; David A Fox
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

10.  Regulation of murine macrophage function by IL-4: IL-4 and IFN-gamma differentially regulate macrophage tumoricidal activation.

Authors:  K Suk; S D Somers; K L Erickson
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.